Suggestions
Andrew Sopko
Courier Health | Redefining how life science companies engage & support patients
Andrew Sopko is a Business Development Executive at Courier Health, a New York-based technology company that provides innovative patient engagement solutions for the life sciences industry.1
Professional Background
Andrew Sopko has been working at Courier Health for over 500 days.4 His role involves promoting Courier Health's patient engagement platform, which aims to improve medication adherence and patient outcomes for specialty therapies.1
Education
Andrew Sopko attended Gonzaga University from 2012 to 2015 and obtained a Bachelor of Arts in Business Administration and Management in 2021.3
Career Highlights
Recently, Andrew Sopko expressed pride in Courier Health's growth and announced a partnership with Norwest, indicating the company's continued expansion and success in the healthcare technology sector.5
Contact Information
For professional inquiries, Andrew Sopko can be reached at andrew@courierhealth.com.1 He is based in the New York City Metropolitan Area and has over 500 connections on LinkedIn.2
Andrew Sopko's LinkedIn profile can be found at linkedin.com/in/andrew-sopko-6b209ba4, where more details about his professional experience and accomplishments may be available.2
Highlights
We meet with #biopharma companies at various stages of commercialization. Whether they’re 18+ months out from launch, 12 months out, or ramping up to go-live 6 months from now, the general order of operations goes: 1) Find and hire team 2) Get them up to speed on the program 3) Let them determine tech/system requirements for said team. By thinking in a more traditional “first this, then that” mentality, commercial organizations are missing several key opportunities to redefine the end-to-end #patientexperience. Not only does it increase the risks of settling for “check-the-box” solutions (step 3) as timelines condense and pressure mounts, but it also misses the fundamental interplay between people, process, and technology. Why go through the effort of investing in internal patient-facing teams if you’re not going to empower them with the right processes and technology?
Instead of thinking in a linear, checkbox fashion, best-in-breed programs are thinking different. They’re giving Field Access & Patient Services leaders a strategic seat at the commercial table as early as possible, and they’re moving in parallel, recognizing that they’ll need the right people, processes, and purpose-built technology to deliver a steamlined #patientjourney.
An innovative industry needs innovative solutions, and above and beyond teams deserve above and beyond solutions.
Having spent the last year deeply embedded in #biopharma, getting to know companies developing innovative #raredisease and chronic condition treatments, I was recently reminded of how hard it is for someone outside the industry to understand the robust support needed to get patients on these game-changing therapies.
When the majority of people feel sick, they go to their doctor's office, get a prescription, and head to their local retail pharmacy/drug store to pick up and start the treatment (even that process can be frustrating!). This differs sharply from the patient journey for the nearly 30 million Americans affected by a rare disease. Beyond oftentimes debilitating symptoms and an uncertain journey to diagnosis, these individuals (and their loved ones) have to jump through countless hoops, including but not limited to figuring out what insurance covers, how to pay for the treatment, enrolling in any copay/financial assistance programs, scheduling and completing any required lab work, figuring out where and how to get treatment, navigating titration, and more. Biopharma Patient Access & Support teams provide critical resources, education, and holistic support to help make this journey less daunting.
As we count down to #RareDiseaseDay, it's important to shine a spotlight on these invaluable teams who never stop championing for better patient outcomes.
